RHUMBLINE ADVISERS - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q4 2021. The put-call ratio across all filers is 6.85 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$993,000
+14.4%
35,439
+11.5%
0.00%0.0%
Q4 2021$868,000
-15.8%
31,792
-16.1%
0.00%0.0%
Q3 2021$1,031,000
+60.1%
37,904
+0.7%
0.00%0.0%
Q2 2021$644,000
-24.0%
37,654
-7.2%
0.00%0.0%
Q1 2021$847,000
-14.4%
40,584
-6.1%
0.00%0.0%
Q4 2020$990,000
+46.9%
43,214
+4.6%
0.00%0.0%
Q3 2020$674,000
+6.1%
41,299
-12.0%
0.00%0.0%
Q2 2020$635,000
+24.8%
46,924
+9.2%
0.00%0.0%
Q1 2020$509,000
-50.8%
42,988
+3.4%
0.00%
-50.0%
Q4 2019$1,035,000
+47.6%
41,580
+0.9%
0.00%
+100.0%
Q3 2019$701,000
-24.0%
41,192
+1.7%
0.00%
-50.0%
Q2 2019$922,000
-26.9%
40,495
+3.3%
0.00%0.0%
Q1 2019$1,261,000
+13.2%
39,218
-0.8%
0.00%0.0%
Q4 2018$1,114,000
+44.3%
39,547
+47.3%
0.00%
+100.0%
Q3 2018$772,000
-28.7%
26,847
-7.2%
0.00%
-50.0%
Q2 2018$1,083,000
+10.6%
28,931
+16.2%
0.00%0.0%
Q1 2018$979,000
+21.0%
24,901
-0.2%
0.00%0.0%
Q4 2017$809,000
-12.6%
24,958
-16.0%
0.00%0.0%
Q3 2017$926,000
+12.7%
29,721
+1.1%
0.00%0.0%
Q2 2017$822,000
+72.7%
29,396
+5.9%
0.00%
+100.0%
Q1 2017$476,000
+45.6%
27,771
+2.8%
0.00%0.0%
Q4 2016$327,000
-9.4%
27,012
+18.6%
0.00%0.0%
Q3 2016$361,000
+24.9%
22,771
+1.9%
0.00%0.0%
Q2 2016$289,000
-0.7%
22,341
+46.1%
0.00%0.0%
Q1 2016$291,000
-15.2%
15,293
+0.4%
0.00%0.0%
Q4 2015$343,000
+8.2%
15,228
+12.6%
0.00%0.0%
Q3 2015$317,000
-5.9%
13,528
+14.9%
0.00%0.0%
Q2 2015$337,00011,7750.00%
Other shareholders
INTERSECT ENT INC shareholders Q4 2021
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders